Evolution of TEM-Related Extended-Spectrum β-Lactamases in Korea

ABSTRACT TEM-52, differing from TEM-1 by having the substitutions Glu-104→Lys, Met-182→Thr, and Gly-238→Ser, has previously been described as the most prevalent extended-spectrum β-lactamase (ESBL) in Korea. In a further survey, we discovered the ESBLs TEM-15, which is like TEM-52 but lacks the substitution at residue 182, and TEM-88, which is like TEM-52 with an additional Gly-196→Asp substitution. TEM-88 retained the activity of TEM-52 against moxalactam. Otherwise, the kinetic properties of the three ESBLs failed to show an advantage to this evolution.

[1]  G. Jacoby,et al.  Sequences of the NPS-1 and TLE-1 β-Lactamase Genes , 2001, Antimicrobial Agents and Chemotherapy.

[2]  D. Persing,et al.  Diagnostic molecular microbiology. , 2001, Current clinical topics in infectious diseases.

[3]  R. Bonnet,et al.  Diversity of TEM Mutants in Proteus mirabilis , 1999, Antimicrobial Agents and Chemotherapy.

[4]  K. Choe,et al.  Survey of Extended-Spectrum β-Lactamases in Clinical Isolates of Escherichia coli and Klebsiella pneumoniae: Prevalence of TEM-52 in Korea , 1999, Journal of Clinical Microbiology.

[5]  P. Berche,et al.  A Novel Extended-Spectrum TEM-Type β-Lactamase (TEM-52) Associated with Decreased Susceptibility to Moxalactam inKlebsiella pneumoniae , 1998, Antimicrobial Agents and Chemotherapy.

[6]  N. Woodford,et al.  Molecular bacteriology: protocols and clinical applications , 1998 .

[7]  D. Payne,et al.  Biochemical and Enzyme Kinetic Applications for the Characterization of βLactamases. , 1998, Methods in molecular medicine.

[8]  D. Payne,et al.  Molecular Approaches for the Detection and Identification of β-Lactamases. , 1998, Methods in molecular medicine.

[9]  Frederick E. Petry,et al.  Principles and Applications , 1997 .

[10]  Peter S. Shenkin,et al.  Amino Acid Sequence Determinants of β-Lactamase Structure and Activity , 1996 .

[11]  K. Bush,et al.  TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases , 1996, Antimicrobial agents and chemotherapy.

[12]  J. Knox,et al.  Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure , 1995, Antimicrobial agents and chemotherapy.

[13]  D. Persing,et al.  Diagnostic molecular microbiology : principles and applications , 1993 .

[14]  J M Ghuysen,et al.  A standard numbering scheme for the class A beta-lactamases. , 1991, The Biochemical journal.

[15]  C. Wharton,et al.  Half-time analysis of the integrated Michaelis equation. Simulation and use of the half-time plot and its direct linear variant in the analysis of some alpha-chymotrypsin, papain- and fumarase-catalysed reactions. , 1982, The Biochemical journal.

[16]  A. Harris,et al.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases. , 1975, Journal of general microbiology.